Innate Pharma S.A.

ENXTPA:IPH 株式レポート

時価総額:€162.7m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Innate Pharma バランスシートの健全性

財務の健全性 基準チェック /46

Innate Pharmaの総株主資本は€51.9M 、総負債は€39.1Mで、負債比率は75.3%となります。総資産と総負債はそれぞれ€184.2Mと€132.3Mです。

主要情報

121.3%

負債資本比率

€34.92m

負債

インタレスト・カバレッジ・レシオn/a
現金€91.80m
エクイティ€28.80m
負債合計€122.70m
総資産€151.50m

財務の健全性に関する最新情報

Recent updates

Benign Growth For Innate Pharma S.A. (EPA:IPH) Underpins Its Share Price

May 21
Benign Growth For Innate Pharma S.A. (EPA:IPH) Underpins Its Share Price

Innate Pharma S.A. (EPA:IPH) Annual Results: Here's What Analysts Are Forecasting For This Year

Mar 24
Innate Pharma S.A. (EPA:IPH) Annual Results: Here's What Analysts Are Forecasting For This Year

Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

Dec 21
Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

Analysts' Revenue Estimates For Innate Pharma S.A. (EPA:IPH) Are Surging Higher

Sep 30
Analysts' Revenue Estimates For Innate Pharma S.A. (EPA:IPH) Are Surging Higher

Some Innate Pharma S.A. (EPA:IPH) Analysts Just Made A Major Cut To Next Year's Estimates

Sep 16
Some Innate Pharma S.A. (EPA:IPH) Analysts Just Made A Major Cut To Next Year's Estimates

Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

Jun 09
Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?

News Flash: Analysts Just Made A Massive Upgrade To Their Innate Pharma S.A. (EPA:IPH) Forecasts

Mar 30
News Flash: Analysts Just Made A Massive Upgrade To Their Innate Pharma S.A. (EPA:IPH) Forecasts

Rainbows and Unicorns: Innate Pharma S.A. (EPA:IPH) Analysts Just Became A Lot More Optimistic

Dec 18
Rainbows and Unicorns: Innate Pharma S.A. (EPA:IPH) Analysts Just Became A Lot More Optimistic

Does Innate Pharma (EPA:IPH) Have A Healthy Balance Sheet?

Sep 27
Does Innate Pharma (EPA:IPH) Have A Healthy Balance Sheet?

Innate Pharma S.A. (EPA:IPH) Analysts Are Reducing Their Forecasts For This Year

Aug 04
Innate Pharma S.A. (EPA:IPH) Analysts Are Reducing Their Forecasts For This Year

Industry Analysts Just Made A Dazzling Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

May 12
Industry Analysts Just Made A Dazzling Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

Industry Analysts Just Made A Captivating Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

Apr 13
Industry Analysts Just Made A Captivating Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts

Time To Worry? Analysts Just Downgraded Their Innate Pharma S.A. (EPA:IPH) Outlook

Mar 26
Time To Worry? Analysts Just Downgraded Their Innate Pharma S.A. (EPA:IPH) Outlook

Is Innate Pharma (EPA:IPH) Weighed On By Its Debt Load?

Nov 11
Is Innate Pharma (EPA:IPH) Weighed On By Its Debt Load?

Revenue Downgrade: Here's What Analysts Forecast For Innate Pharma S.A. (EPA:IPH)

May 13
Revenue Downgrade: Here's What Analysts Forecast For Innate Pharma S.A. (EPA:IPH)

Is Innate Pharma (EPA:IPH) Using Debt Sensibly?

May 04
Is Innate Pharma (EPA:IPH) Using Debt Sensibly?

財務状況分析

短期負債: IPHの 短期資産 ( €148.0M ) が 短期負債 ( €39.6M ) を超えています。

長期負債: IPHの短期資産 ( €148.0M ) が 長期負債 ( €92.7M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: IPH総負債よりも多くの現金を保有しています。

負債の削減: IPHの負債対資本比率は、過去 5 年間で1.5%から75.3%に増加しました。


貸借対照表


キャッシュ・ランウェイ分析

過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。

安定したキャッシュランウェイ: IPHは、現在の フリーキャッシュフロー に基づき、3 年以上にわたって十分な キャッシュランウェイ を有しています。

キャッシュランウェイの予測: IPHの フリー キャッシュ フロー が過去のレートに基づいて増加または減少し続ける場合、十分な キャッシュ ランウェイ があるかどうかを判断するためのデータが不十分です。


健全な企業の発掘